Ignite Creation Date:
2025-12-26 @ 10:46 PM
Ignite Modification Date:
2026-03-02 @ 6:02 PM
Study NCT ID:
NCT00990912
Status:
COMPLETED
Last Update Posted:
2010-02-05
First Post:
2009-10-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002)
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-01
Start Date Type:
None
Primary Completion Date:
2005-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-11
Completion Date Type:
ACTUAL
First Submit Date:
2009-10-05
First Submit QC Date:
None
Study First Post Date:
2009-10-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-02-05
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2010-02-03
Last Update Post Date:
2010-02-05
Last Update Post Date Type:
ESTIMATED